Opioid Withdrawal Treatment Market Synopsis, Treatment Overview, Industry Share, Comprehensive Challenges and Global Forecast to 2025


Market Highlights:

The global Opioid Withdrawal Treatment Market held a market value of USD 1.8 billion in 2018 and is projected to grow at a CAGR of 10.1% over the forecast period. Opioids are drugs such as heroin, opium, morphine, codeine, and methadone that are used in cases of severe, postsurgical, or chronic pain. In some cases, usage of opioids causes addiction, and Opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment.

Browse Full Report Details TOC Exclusively @ https://www.marketresearchfuture.com/reports/opioid-withdrawal-treatment-market-8123

Key Players:

·         Merck & Co
·         Teva Pharmaceutical Industries Ltd
·         Pfizer Inc.
·         Novartis
·         Sanofi
·         Johnson & Johnson Services
·         F. Hoffmann-La Roche Ltd
·         Bayer AG among others
.
Segmentation:

·         The global opioid withdrawal treatment market has been segmented into drug type and distribution channel.
·         By drug type, the market has been segmented into the nonsteroidal anti-inflammatory drugs, anti-nausea medications, analgesics, natural sleep supplements, and others.
·         On the basis of distribution channel, the market has been segmented into hospital pharmacy, retail pharmacies, and online stores.

Regional Analysis:

On a regional basis, the Americas is anticipated to dominate the global opioid withdrawal treatment market owing to the owing to increasing geriatric population, high prevalence of various chronic diseases, and rising adoption of opioids for the management of pain.
According to the Substance Abuse and Mental Health Services Administration (SAMHSA) in the National Survey on Drug Use and Health (NSDUH), about 30.5 million Americans aged 12 or older were using illicit drugs in 2018. Additionally, rising demand for advanced treatment and growing healthcare expenditure is driving the growth of the market. For instance, according to the American College of Cardiology Foundation, coronary heart disease (CHD) is the leading cause of deaths attributable to CV in the US. CHD contributes to over 43.8% of death cases in the US. Additionally, in 2015, the total healthcare expenditure for CVD and stroke in the US was an estimated USD 329.7 billion. CVD and stroke accounted for 14% of total health expenditures in 2015.
Europe accounts for the second-largest market and holds a healthy share in the global opioid withdrawal treatment market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and flourishing pharmaceutical industry due to the presence of major market players.
Asia-Pacific is expected to be the fastest-growing market, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and availability of favorable insurance policies.
The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access, and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of the healthcare industry and the rising availability of specialty care centers.

About Market Research Future: 

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more